CLINICAL_TRIALS
trial_result
· 2010-03-03
Clinical Trial Update: CO2 Inhalation as a New Treatment Modality for Apnea of Prematurity [Phase 2, Phase 3]
Summary
The document reports the completion of Phase 2 and Phase 3 trials evaluating carbon dioxide inhalation as a treatment for apnea of prematurity, led by the Unive…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Manitoba | Conditions: Apnea of Prematurity | Phase 2, Phase 3 | Status: COMPLETED